Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648022 · ClinicalTrials.gov registry record · NA
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT02648022: Completed NA study, sponsored by VA Office of Research and Development.
NCT02648022 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02648022, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
To determine the effect of an integrated care protocol on antiviral treatment and sustained virologic response (SVR) rates following initiation of direct acting antiviral therapies (DAA) treatments in 2011.
Interventions
- BEHAVIORAL Brief mental health interventions and case management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02648022
The ClinicalTrials.gov registry entry for NCT02648022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief mental health interventions and case management is the first listed.
NCT02648022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02648022 about?
NCT02648022 is a clinical study titled "Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment". To determine the effect of an integrated care protocol on antiviral treatment and sustained virologic response (SVR) rates following initiation of direct acting antiviral therapies (DAA) treatments in 2011.
What is the current status of trial NCT02648022?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2012-01. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02648022?
The interventions under investigation include: Brief mental health interventions and case management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02648022?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.